Document is current
Any future updates will be listed below
-
Authors
Hull, Leland E. https://orcid.org/0000-0002-5736-6543
Brodney, Suzanne
Regan, Susan
Benson, Olivia
Gallagher, Katherine L.
Marotta, Caylin
Ritchie, Olivia
Shannon, Kristen M.
Verwillow, Anna
Rehm, Heidi L.
Haas, Jennifer S.
-
Funding
Funding for this research was provided by:
Center for the Transformation of Internal Medicine
National Human Genome Research Institute (K08HG012221)
Cystic Fibrosis Foundation (2023A065961)
- License Information
-
More Information
Article History
Received: 10 July 2025
Accepted: 1 December 2025
First Online: 5 January 2026
Declarations
:
: This study was deemed exempt by the Mass General Brigham Institutional Review Board (Protocol # 2023P000751). A waiver of written informed consent was granted. Survey participants indicated consent at the start of their survey, and referring providers provided verbal consent at the start of their interview.
: Dr. Rehm has received research funding from Illumina and Microsoft and owns stock in Genome Medical. The other authors declare no conflict of interest.
